Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option? - Test2 - elhamkhani - TriplyDB

Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?

Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?

http://www.wikidata.org/entity/Q26781365

about

XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.Synthesis and Biological Evaluation of 7-Deoxy-Epothilone Analogues.Tubulin alpha 8 is expressed in hepatic stellate cells and is induced in transformed hepatocytes.Modeling Cancer Cell Growth Dynamics In vitro in Response to Antimitotic Drug Treatment Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.Marine Sponge Natural Products with Anticancer Potential: An Updated Review.Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer.Interactome Analysis of Microtubule-targeting Agents Reveals Cytotoxicity Bases in Normal Cells.Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting.Polymer conjugate of a microtubule destabilizer inhibits lung metastatic melanoma.Human MAP Tau Based Targeted Cytolytic Fusion Proteins.Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C.Indibulin dampens microtubule dynamics and produces synergistic antiproliferative effect with vinblastine in MCF-7 cells: Implications in cancer chemotherapy

P2860

Q27333970-01B85532-5F43-4547-A016-BD13E2EED322 Q28077780-F49F28AA-320A-4805-A372-5753F2F49196 Q37392573-77B7B79F-D83F-482F-8EFA-11E064D67396 Q37645090-D773A894-6EC2-4FAD-9804-3A20780C8A2A Q37729318-24D60E53-F8CF-4FD9-9092-F099C0F17A0E Q38722541-4B9351A4-2354-4F66-A39B-20717C1A97D2 Q41598812-90776A5F-5B68-4F82-AD2A-F172A818C6ED Q41817690-64D2269D-A743-4571-8E98-80288F4A4F7A Q43245354-0F3D7BF2-5CE7-4DCE-BAAB-36F5830E2239 Q47119995-018890CB-0D43-499C-82D4-308C90396EEA Q47288270-D78308F1-622A-4C2A-A9D8-8F641FD9DC63 Q48202119-FDB53914-48C5-424E-972E-A9AC98C93F00 Q48336429-01877CAB-290F-4560-9EBD-F739FC8B9AB3 Q50921086-86A05A00-B98F-4626-A33A-F82C254D232A Q51141565-3AB80CA8-3CED-4F1A-BE72-3AA1B0725AFF Q58771071-560FD7E9-7F53-4B19-A1A2-3ED38FFC9CF1

P2860

Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?

http://www.wikidata.org/entity/Q26781365

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@ast

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@en

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@nl

type

label

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@ast

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@en

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@nl

prefLabel

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@ast

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@en

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@nl

P1433

Q26781365-4543AE2E-E896-4EC8-9F0A-9386F0535775

P1476

Q26781365-A5586F0B-539A-430E-B650-C3833B980265

P2093

Q26781365-0EF1416A-B93E-4B47-AC48-E51831B53BAE

Q26781365-1515A67E-07BC-439F-AC83-C02C1525ABC5

Q26781365-53BC8D37-1594-4935-BFAA-D0BF30A322DB

Q26781365-7BDA2B5A-C88B-413B-B2F3-89A79A99404C

Q26781365-7EAA5CEE-BDFA-472E-A5A4-E6AE4D2BCA01

Q26781365-8D05D961-23B2-408B-B441-9A5144FDC347

Q26781365-905D80C6-5AA1-40FB-A2A5-3A19EDC458A4

Q26781365-9D752055-A967-461C-890D-4CB1C7D207FF

Q26781365-9DA070A8-7CE2-4922-834F-EF6C17F4AE09

Q26781365-A6648903-55BD-4D1C-B339-3CE595DE0F85

P275

Q26781365-1D84929C-5342-464E-9CB0-A5D9D940FBA7

P2860

Q26781365-004C1840-5EBB-49EF-9F40-EA290ED96852

Q26781365-0063C07A-841D-40AB-9873-CD58E61D2E44

Q26781365-030AC15E-4838-409D-B158-2DD1FC0F0072

Q26781365-0327C89D-5038-42BA-B2DB-F2ECB31A8B80

Q26781365-05E1FF75-D61C-4403-9F09-ECA070CEC47E

Q26781365-0601C8DC-FA8E-49DE-8E31-8B10A71CEB2D

Q26781365-07F2DCF2-886A-4B64-84D9-172A34B61A54

Q26781365-087058D7-6E7A-4BB6-84E8-9B423065D338

Q26781365-088ABF3D-4274-461A-898B-D68DAEE2202E

Q26781365-0954050A-C936-4290-A9C7-6FF235025F21

P304

Q26781365-77980CD3-8300-498F-9C00-81F22D16E1FB

P31

Q26781365-4058ACC9-5E87-478A-9D86-BA6A7D55C976

P3181

Q26781365-E8C2EF1E-C61F-4E69-A967-2974654D787D

P356

Q26781365-7080BFFC-D063-414C-9ECF-AAEFA3A88D38

P407

Q26781365-E39806AD-DDF2-4437-B708-CAE68BAB20F2

P478

Q26781365-115B54D2-9FC0-4C59-BA28-F3E227DB64A8

P50

Q26781365-3E73F6F6-065C-4694-9727-303C45D63F4B

P5008

Q26781365-78EA45FB-999D-4312-841C-B0B6AF7F4F17

P577

Q26781365-EE71DBF3-9849-47CA-8082-EB277B825CC0

P5875

Q26781365-B3A1766E-2692-4296-8A86-BEA476C3E864

P698

Q26781365-216DF119-1A5A-441F-9E7D-4EBA0EFE2ED4

P921

Q26781365-6F2EECDD-698D-4E94-B0CA-7700F907AD95

Q26781365-7B3F99E9-1AB1-4AF7-B22F-847C039F9307

Q26781365-DDAE7AE5-8FF1-4BD3-A2D2-14A3423C4832

P932

Q26781365-6171792A-B6A2-42F2-802B-22B920D5DD4E

P3181

P356

P1433

Cellular Oncology

P1476

Stabilizing versus destabilizi ...... ctive cancer treatment option?

@en

P2093

Alessandro Perez

http://www.w3.org/2001/XMLSchema#string

Angela Listì

http://www.w3.org/2001/XMLSchema#string

Antonina Cangemi

http://www.w3.org/2001/XMLSchema#string

Daniela Massihnia

http://www.w3.org/2001/XMLSchema#string

Daniele Fanale

http://www.w3.org/2001/XMLSchema#string

Florinda Di Piazza

http://www.w3.org/2001/XMLSchema#string

Francesca Toia

http://www.w3.org/2001/XMLSchema#string

Francesco Passiglia

http://www.w3.org/2001/XMLSchema#string

Giuseppe Bronte

http://www.w3.org/2001/XMLSchema#string

Giuseppe Cicero

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups

Vinca alkaloids

Structural basis of microtubule stabilization by laulimalide and peloruside A

Microtubule-binding agents: a dynamic field of cancer therapeutics.

Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer

Induction of apoptosis by cryptophycin 1, a new antimicrotubule agent

Microtubule polymerization dynamics

Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region

Efficient, divergent synthesis of cryptophycin unit A analogues

betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer

P304

690916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4518964

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2015/690916

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Marta Castiglia

P5008

P577

2015-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283669632

http://www.w3.org/2001/XMLSchema#string

P698

26484003

http://www.w3.org/2001/XMLSchema#string

P921

P932

4592889

http://www.w3.org/2001/XMLSchema#string